Literature DB >> 2213799

Dysphagia in the elderly: what does it mean to the endoscopist?

P Bannister1, A J Stanners, R A Mountford.   

Abstract

The role of fibreoptic endoscopy in the investigation of dysphagia in an elderly population was investigated. Three hundred and sixty-five subjects were studied. Two hundred and sixty subjects had abnormalities with extra oesophageal disease accounting for symptoms in a substantial minority. Endoscopy was safe, offered the advantage of immediate therapy and was well tolerated. Sub-group analysis showed it to be preferable to radiological investigation in diagnosing both benign and malignant mucosal lesions.

Entities:  

Mesh:

Year:  1990        PMID: 2213799      PMCID: PMC1292811          DOI: 10.1177/014107689008300906

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  5 in total

1.  Endoscopic insertion of palliative oesophageal tubes in oesophagogastric neoplasms.

Authors:  D B Jones; P S Davies; P M Smith
Journal:  Br J Surg       Date:  1981-03       Impact factor: 6.939

2.  Efficacy of radiology of the esophagus for evaluation of dysphagia.

Authors:  D J Ott; W C Wu; D W Gelfand
Journal:  Gastrointest Radiol       Date:  1981

3.  Radiological assessment of dysphagia with endoscopic correlation.

Authors:  R D Halpert; P J Feczko; E M Spickler; L V Ackerman
Journal:  Radiology       Date:  1985-12       Impact factor: 11.105

4.  Upper gastrointestinal endoscopy in patients aged 80 years or more.

Authors:  B T Cooper; C S Neumann
Journal:  Age Ageing       Date:  1986-11       Impact factor: 10.668

5.  Endoscopic evaluation of dysphagia in the elderly.

Authors:  S D Gupta; L V Petrus; F J Gibbins; A W Dellipiani
Journal:  Age Ageing       Date:  1987-05       Impact factor: 10.668

  5 in total
  1 in total

1.  Aspiration: the predictive value of some clinical and endoscopy signs. Evaluation of our case series.

Authors:  D Farneti; P Consolmagno
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-02       Impact factor: 2.124

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.